RxDoctor Payments Data

Erica Hayes, MD

Psychiatry · Beaumont, TXNPI 1851429757

Payments from drug & device makers

$889in general payments, 2019–2025

Across 84 payments — averaging $10.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$318
  • Lundbeck LLC$156
  • Takeda Pharmaceuticals U.S.A., Inc.$80
  • Shire North American Group Inc$74
  • Neurocrine Biosciences, Inc.$58
  • Vanda Pharmaceuticals Inc.$57
  • plus $146 from 5 others

What the payments were for

  • Food & beverage$889100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$889 in reported general payments places this provider in the 65th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas

Medicare billing

Part B allowed, 2024
$31,369
Medicare patients
77
Services billed
404

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole41$70,762
VraylarCariprazine Hcl37$57,370
TrintellixVortioxetine Hydrobromide57$38,878
CymbaltaDuloxetine Hcl13$9,501
Quetiapine Fumarate247$8,538
Bupropion XlBupropion Hcl267$6,716
Aripiprazole155$6,661
Desvenlafaxine Succinate ErDesvenlafaxine Succinate124$4,234
Duloxetine Hcl140$2,480
Trazodone Hcl257$2,424
Buspirone Hcl186$2,405
Mirtazapine178$2,028
Oxcarbazepine54$1,885
Olanzapine59$1,789
Divalproex Sodium ErDivalproex Sodium67$1,450

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$318$70,76241 claims
AbbVieVraylar$44$57,37037 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$80$38,87857 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,238 psychiatry providers in Texas.

Other psychiatry in Beaumont

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →